Commercialisation of health care in US distorts resource allocation, expert saysBMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39486.688356.DB (Published 14 February 2008) Cite this as: BMJ 2008;336:349
- David Spurgeon
The failure of the United States to contain medical costs, which now exceed $2.1 trillion (£1.1 trillion; €1.4 trillion) a year or more than $7000 for every man, woman, and child in the country, results primarily from the unique and pervasive commercialisation of the sector, an article in this week’s New England Journal of Medicine says (2008;358:549-51).
Inthe perspective article Robert Kuttner, coeditor of the magazine The American Prospect and a senior fellow at Demos, a public policy research and advocacy organisation based in New York, contends that what raises costs and distorts resource allocation are “the dominance of for-profit insurance and pharmaceutical companies, a new wave of investor-owned specialty …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial